$342 Million is the total value of Bill & Melinda Gates Foundation's 10 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVAC | CUREVAC N V | $171,200,000 | -25.6% | 3,134,780 | 0.0% | 50.12% | +41.8% | |
| New | LUMIRADX LIMITED | $46,100,000 | – | 5,574,059 | +100.0% | 13.50% | – | |
| BNTX | Sell | BIONTECH SEsponsored ads | $40,600,000 | -82.6% | 148,674 | -85.7% | 11.88% | -66.8% |
| VIR | Sell | VIR BIOTECHNOLOGY INC | $29,500,000 | -77.5% | 677,777 | -75.6% | 8.64% | -57.1% |
| IMCR | IMMUNCORE HLDGS PLCads | $21,400,000 | -7.0% | 576,923 | 0.0% | 6.26% | +77.3% | |
| BFLY | BUTTERFLY NETWORK INC | $10,600,000 | -29.3% | 1,011,003 | 0.0% | 3.10% | +34.6% | |
| New | SERA PROGNOSTICS INC | $8,700,000 | – | 779,814 | +100.0% | 2.55% | – | |
| BCEL | ATRECA INC | $8,700,000 | -27.5% | 1,396,644 | 0.0% | 2.55% | +38.1% | |
| AMRS | AMYRIS INC | $4,000,000 | -16.7% | 292,398 | 0.0% | 1.17% | +58.7% | |
| ZY | ZYMERGEN INC | $800,000 | -60.0% | 59,970 | 0.0% | 0.23% | -23.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CUREVAC N V | 12 | Q3 2023 | 58.0% |
| VIR BIOTECHNOLOGY INC | 12 | Q3 2023 | 32.0% |
| BIONTECH SE | 12 | Q3 2023 | 35.8% |
| ATRECA INC | 12 | Q3 2023 | 5.3% |
| AMYRIS INC | 12 | Q3 2023 | 1.2% |
| IMMUNCORE HLDGS PLC | 11 | Q3 2023 | 35.7% |
| BUTTERFLY NETWORK INC | 11 | Q3 2023 | 3.8% |
| LUMIRADX LTD | 8 | Q3 2023 | 18.0% |
| EXSCIENTIA | 8 | Q3 2023 | 13.3% |
| ZYMERGEN INC | 6 | Q3 2022 | 0.3% |
View Bill & Melinda Gates Foundation's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LumiraDx Ltd | August 03, 2022 | 19,859,773 | 15.8% |
| Atreca, Inc. | February 16, 2021 | 1,396,644 | 4.7% |
| Liquidia Technologies Inc | February 12, 2020 | 119,678 | 0.5% |
| X4 Pharmaceuticals, Inc | March 15, 2019 | 120,363 | 1.8% |
| Arsanis, Inc. | February 13, 2018 | 722,179 | 5.1% |
View Bill & Melinda Gates Foundation's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| SC 13D | 2022-08-03 |
| SC 13G | 2022-07-15 |
| 13F-HR | 2022-05-13 |
View Bill & Melinda Gates Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.